Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsThe public healthcare sector is struggling to cope up with a myriad of problems –governments are unable to meet healthcare demands, suffer from lack of infrastructure and lack access to evolving technologies. In response, the collaboration of the government with private sectors – Public-Private Partnerships (PPPs) have emerged as an effective solution to fill these gaps.
In the Malaysian healthcare sector, the PPP model has contributed towards greater access to comprehensive healthcare, along with quality management and service delivery through various funding and sponsorship programs. One of which was the National immunization program (2019), where 80% of Malaysian adults (~19M people) achieved vaccination within a span of 7 months.
This white paper will highlight the concept of PPPs and its landscape in Malaysia, impact of COVID-19 in accelerating such partnerships and other possible models supported by successful case studies in UK, India, and Valencia.
To find out more public-private partnerships and solutions to improve patient access, please contact us.